Unlock instant, AI-driven research and patent intelligence for your innovation.

Externally applied pharmaceutical preparation for treating skin superficial fungal infections

A topical drug, fungal infection technology, applied in antifungal agents, medical preparations containing active ingredients, skin diseases, etc., to achieve the effects of great clinical application value, saving treatment costs, and low recurrence rate

Inactive Publication Date: 2015-01-28
南昌肤瑞生物科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

By searching the literature at home and abroad, there is no literature report that 2-hydroxy-3-carbonyl-23-norolean-1,4,12-triene-28-acid has biological activity against fungal infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Externally applied pharmaceutical preparation for treating skin superficial fungal infections

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The preparation of embodiment 1 external film preparation

[0020] (1) Weigh 10g of polyvinyl alcohol 05-88 and 4g of sodium carboxymethyl cellulose, respectively add 30 and 40ml of purified water to moisten, stir, soak for 36 hours to make it fully swell, and then heat in a water bath at 90°C until dissolved. Get polyvinyl alcohol 05-88 mucilage liquid and carboxymethyl cellulose sodium mucilage liquid respectively, and set aside.

[0021] (2) Weigh 0.5g of 2-hydroxy-3-carbonyl-23-norolean-1,4,12-triene-28-acid in a mortar, add 2g of azone, 2g of Tween-80 , 1g glycerin, and the polyvinyl alcohol 05-88 mucilage solution and sodium carboxymethylcellulose mucilage solution prepared in step (1), and grind them while adding until they are evenly ground. , to obtain the drug film slurry.

[0022] (3) Pour the drug film slurry on a sterile glass plate, spread it evenly, and dry it in an oven at 65°C. After the film is formed, remove the film and cut it into 6cm×8cm small p...

Embodiment 2

[0023] The preparation of embodiment 2 external film preparation

[0024] (1) Weigh 30g of polyvinyl alcohol 05-88 and 10g of sodium carboxymethyl cellulose, respectively add 100ml of purified water to moisten, stir, and soak for 48 hours to make them fully swell, and then heat in a water bath at 90°C until dissolved, respectively, to obtain Polyvinyl alcohol 05-88 mucilage and sodium carboxymethyl cellulose mucilage, for later use.

[0025] (2) Weigh 1g of 2-hydroxy-3-carbonyl-23-norolean-1,4,12-triene-28-acid in a mortar, add 5g of azone, 5g of Tween-80, 3g of glycerin, as well as the polyvinyl alcohol 05-88 mucilage prepared in step (1) and sodium carboxymethyl cellulose mucilage, grind them while adding until they are evenly ground, then place them in a water bath at 60°C for 30 minutes, remove the air bubbles, Get the medicine film slurry.

[0026] (3) Pour the drug film slurry on a sterile glass plate, spread it evenly, and dry it in an oven at 65°C. After the film i...

Embodiment 3

[0029] Example 3 Experimental Study on the Treatment of Drugs to Trichophyton mentagrophytes Infected Guinea Pig Model

[0030] Select Trichophyton mentagrophytes ( Trichophyton mentagrophytes ) ATCC4439 was used as a pathogenic bacterium, its virulence was recovered before the experiment, and it was inoculated on a sandcastle agar (SDA) slant test tube, cultured at 26°C, and the colonies were carefully scraped after 7-10 days, and the infectious fungal suspension was prepared with normal saline for later use . SDA consisted of 4% glucose, 1% peptone and 2% agar.

[0031] 36 healthy white guinea pigs, both male and female, weighing 250-350g. Cut short the long hairs on the abdomen and back of all white guinea pigs, and then remove the hair with a razor to make an 8cm×10cm hair removal area, and apply an appropriate amount of glycerin on the hair removal area to prevent the skin from drying out, and then rub the hair removal area repeatedly with sandpaper Skin, the damage...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an externally applied pharmaceutical preparation for treating skin superficial fungal infections. The pharmaceutical preparation is prepared from an active ingredient and additives, wherein the active ingredient comprises 2-hydroxy-3-carbonyl-23-norolean-1, 4, 12-triene-28-acid or a derivative thereof. The invention provides a medicine prepared from 2-hydroxy-3-carbonyl-23-norolean-1, 4, 12-triene-28-acid or the derivative thereof for treating the skin superficial fungal infections, and the medicine has a good treatment effect and low recurrence rate.

Description

technical field [0001] The invention belongs to the technical field of dermatological drug preparations, and in particular relates to an external drug preparation for treating skin superficial fungal infection. Background technique [0002] Tinea manuum, tinea pedis, tinea corporis, jock itch and other tinea diseases caused by superficial fungal infection of the skin are stubborn and intractable skin diseases caused by superficial fungal infection, manifested as water rash, keratinized and scaly patches, The main pathogens are Trichophyton mentagrophytes and Trichophyton rubrum. Generally, it can be divided into three types: maceration type, blister type and scaly keratosis type. Dipping type—generally, the skin between fingers and toes is soaked, turned white, and the epidermis is rubbed off, exposing the red erosive surface, which is prone to secondary infection; Mainly thickened, with clear boundaries and vesicles between them. According to the different parts of ringw...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/56A61P31/10A61P17/00
CPCA61K31/56
Inventor 李健
Owner 南昌肤瑞生物科技有限公司